Karyopharm Therapeutics
KPTI
KPTI
106 hedge funds and large institutions have $563M invested in Karyopharm Therapeutics in 2019 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 40 increasing their positions, 25 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.69% more ownership
Funds ownership: 5.6% → 6.3% (+0.69%)
3% less call options, than puts
Call options by funds: $3.67M | Put options by funds: $3.78M
Holders
106
Holding in Top 10
1
Calls
$3.67M
Puts
$3.78M
Top Buyers
| 1 | +$58.2M | |
| 2 | +$19.5M | |
| 3 | +$16.4M | |
| 4 |
ECP
Elk Creek Partners
Denver,
Colorado
|
+$12.2M |
| 5 |
Millennium Management
New York
|
+$11.7M |
Top Sellers
| 1 | -$25.8M | |
| 2 | -$20M | |
| 3 | -$15.6M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$8.41M |
| 5 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$4.04M |